Menu

1 / 2

Acadia Pharmaceuticals Inc. (ACAD) Presents at UBS Global Biopharma Conference 2026 Transcript

All Articles on Seeking Alpha·1 day ago
#JuYoI4YZ
#seekingalpha#million#growth#delivered#photo
Reading 0:00
15s threshold

SA Transcripts 163.07K Followers

Acadia Pharmaceuticals Inc. (ACAD) UBS Global Biopharma Conference 2026 November 17, 2026 7:40 AM EST

Company Participants

Catherine Owen Adams - CEO & Director

Conference Call Participants

Ashwani Verma - UBS Investment Bank, Research Division

Presentation

Ashwani Verma

UBS Investment Bank, Research Division

Good day, everybody. My name is Ash Verma. I cover SMID-cap Biotech and Spec Pharma at UBS and really excited to host Acadia Pharmaceuticals. And for -- just to give a quick background, Acadia has DAYBUE and NUPLAZID, but I will just, like, pass it on to Catherine, like, if you can talk a little bit about the story in terms of where the focus of the growth opportunities is for both the products, and then you can talk about the pipeline and other things after that.

Catherine Owen Adams

CEO & Director

Sounds good. So we just delivered our quarter results.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.